BioCentury
ARTICLE | Clinical News

Paquinimod regulatory update

May 5, 2014 7:00 AM UTC

Active Biotech disclosed in its 1Q14 earnings that in January FDA granted Orphan Drug designation to paquinimod to treat systemic sclerosis. The small molecule quinoline-3-carboxamide immunomodulator ...